Capital Analysts, LLC Cns Pharmaceuticals, Inc. Transaction History

Capital Analysts, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.26 - $1.05 $260 - $1,050	-1,000 Closed	0 $0
Q2 2021 Nov 15, 2021	SELL	$1.71 - $2.42 $6,840 - $9,680	-4,000 Reduced 80.0%	1,000 $2,000
Q2 2021 Aug 05, 2021	BUY	$1.71 - $2.42 $6,840 - $9,680	4,000 Added 400.0%	5,000 $10,000
Q1 2021 May 17, 2021	BUY	$1.72 - $4.18 $1,720 - $4,180	1,000 New	1,000 $2,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.